Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 7 · 100%Moderate 0 · 0%High 0 · 0%

Desloratadine 5 to 20 mg vs placebo

Complete suppression of urticaria: short‐term duration of intervention (desloratadine 5 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria

1 finding from 1 review

H1‐antihistamines for chronic spontaneous urticaria 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 46 participants
Low

Desloratadine 5 to 20 mg vs placebo

Complete suppression of urticaria: short‐term duration of intervention (desloratadine 10 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria

1 finding from 1 review

H1‐antihistamines for chronic spontaneous urticaria 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 46 participants
Low

Desloratadine 5 to 20 mg vs placebo

Complete suppression of urticaria: short‐term duration of intervention (desloratadine 20 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria

1 finding from 1 review

H1‐antihistamines for chronic spontaneous urticaria 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 46 participants
Low

Desloratadine 5 to 20 mg vs placebo

Complete suppression of urticaria: intermediate‐term duration of intervention (desloratadine 5 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria

1 finding from 1 review

H1‐antihistamines for chronic spontaneous urticaria 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Low

Desloratadine 5 to 20 mg vs placebo

Adverse effects requiring withdrawal/discontinuation of study medication · patients with chronic spontaneous urticaria

Desloratadine 5 to 20 mg showed no clear difference in adverse effects leading to withdrawal: intermediate‐term duration of… compared with placebo (low certainty).

1 finding from 1 review

H1‐antihistamines for chronic spontaneous urticaria 2014 · Cochrane Headline outcomes only
RR 1.46 [0.42, 5.1]
3 studies · 466 participants
Low

Loratadine 10 mg vs desloratadine 5 mg

Complete suppression of urticaria: intermediate‐term duration of intervention · patients with chronic spontaneous urticaria

Loratadine 10 mg showed no clear difference in complete suppression of urticaria: intermediate‐term duration of… compared with desloratadine 5 mg (low certainty).

1 finding from 1 review

H1‐antihistamines for chronic spontaneous urticaria 2014 · Cochrane Headline outcomes only
RR 0.91 [0.78, 1.06]
2 studies · 369 participants
Low

Loratadine 10 mg vs desloratadine 5 mg

Good or excellent response: intermediate‐term duration of intervention Global assessment of symptom scores · patients with chronic spontaneous urticaria

Loratadine 10 mg showed no clear difference in good or excellent response: intermediate‐term duration of… compared with desloratadine 5 mg (low certainty).

1 finding from 1 review

H1‐antihistamines for chronic spontaneous urticaria 2014 · Cochrane Headline outcomes only
RR 1.04 [0.64, 1.71]
3 studies · 410 participants
Low